We demonstrated that miR-195 promotes glioma cell proliferation by directly targeting the 3′-UTRs of cyclin D1 and cyclin E1, consequently reducing phosphorylation of pRb and downregulating the proliferative marker PCNA. Here, CCND1 is linked to central nervous system cancer.